These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

608 related items for PubMed ID: 19051848

  • 1. The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.
    Thomas TL.
    Pediatr Nurs; 2008; 34(5):429-31. PubMed ID: 19051848
    [Abstract] [Full Text] [Related]

  • 2. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
    Broomall EM, Reynolds SM, Jacobson RM.
    Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
    [Abstract] [Full Text] [Related]

  • 3. Quadrivalent human papillomavirus vaccine.
    Barr E, Tamms G.
    Clin Infect Dis; 2007 Sep 01; 45(5):609-7. PubMed ID: 17682997
    [Abstract] [Full Text] [Related]

  • 4. Harnessing the power of prevention: human papillomavirus vaccines.
    Mayeaux EJ.
    Curr Opin Obstet Gynecol; 2006 Feb 01; 18 Suppl 1():s15-21. PubMed ID: 16520680
    [Abstract] [Full Text] [Related]

  • 5. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
    Stanley M.
    Gynecol Oncol; 2007 Nov 01; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
    [Abstract] [Full Text] [Related]

  • 6. A brief history of economic evaluation for human papillomavirus vaccination policy.
    Beutels P, Jit M.
    Sex Health; 2010 Sep 01; 7(3):352-8. PubMed ID: 20719227
    [Abstract] [Full Text] [Related]

  • 7. Reducing the health burden of HPV infection through vaccination.
    Soper D.
    Infect Dis Obstet Gynecol; 2006 Sep 01; 2006 Suppl():83084. PubMed ID: 16967913
    [Abstract] [Full Text] [Related]

  • 8. Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
    Knudtson M, Tiso S, Phillips S.
    Nurs Clin North Am; 2009 Sep 01; 44(3):293-9. PubMed ID: 19683091
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY.
    Vaccine; 2008 Jul 29; 26(32):4080-93. PubMed ID: 18550229
    [Abstract] [Full Text] [Related]

  • 13. HPV vaccine and its recommendations, 2007.
    Zimmerman RK.
    J Fam Pract; 2007 Feb 29; 56(2 Suppl Vaccines):S1-5, C1. PubMed ID: 17270106
    [Abstract] [Full Text] [Related]

  • 14. Cost–effectiveness of catch-up programs in human papillomavirus vaccination.
    de Peuter MA, Littlewood KJ, Annemans L, Largeron N, Quilici S.
    Expert Rev Vaccines; 2010 Oct 29; 9(10):1187-201. PubMed ID: 20923269
    [Abstract] [Full Text] [Related]

  • 15. Lessons from the failure of human papillomavirus vaccine state requirements.
    Schwartz JL, Caplan AL, Faden RR, Sugarman J.
    Clin Pharmacol Ther; 2007 Dec 29; 82(6):760-3. PubMed ID: 17971822
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses].
    Westra TA, Daemen T, Postma MJ, Wilschut JC.
    Ned Tijdschr Geneeskd; 2009 Dec 29; 153():A356. PubMed ID: 19930733
    [Abstract] [Full Text] [Related]

  • 20. Vaccines for human papillomavirus infection: a critical analysis.
    Nath AK, Thappa DM.
    Indian J Dermatol Venereol Leprol; 2009 Dec 29; 75(3):245-53; quiz 254. PubMed ID: 19439876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.